annual CFO:
-$167.65M-$179.57M(-1506.55%)Summary
- As of today (September 18, 2025), AMLX annual cash flow from operations is -$167.65 million, with the most recent change of -$179.57 million (-1506.55%) on December 31, 2024.
- During the last 3 years, AMLX annual CFO has fallen by -$92.85 million (-124.13%).
- AMLX annual CFO is now -1506.55% below its all-time high of $11.92 million, reached on December 31, 2023.
Performance
AMLX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$25.25M+$14.58M(+36.60%)Summary
- As of today (September 18, 2025), AMLX quarterly cash flow from operations is -$25.25 million, with the most recent change of +$14.58 million (+36.60%) on June 1, 2025.
- Over the past year, AMLX quarterly CFO has increased by +$41.33 million (+62.08%).
- AMLX quarterly CFO is now -286.32% below its all-time high of $13.55 million, reached on December 31, 2023.
Performance
AMLX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$165.65M+$41.33M(+19.97%)Summary
- As of today (September 18, 2025), AMLX TTM cash flow from operations is -$165.65 million, with the most recent change of +$41.33 million (+19.97%) on June 1, 2025.
- Over the past year, AMLX TTM CFO has dropped by -$106.96 million (-182.26%).
- AMLX TTM CFO is now -1103.82% below its all-time high of $16.50 million, reached on March 31, 2024.
Performance
AMLX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AMLX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1506.5% | +62.1% | -182.3% |
| 3 y3 years | -124.1% | +45.7% | -90.2% |
| 5 y5 years | -1468.7% | - | - |
AMLX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1506.5% | +6.8% | -286.3% | +62.1% | -1103.8% | +20.0% |
| 5 y | 5-year | -1506.5% | +6.8% | -286.3% | +62.1% | -1103.8% | +20.0% |
| alltime | all time | -1506.5% | +6.8% | -286.3% | +62.1% | -1103.8% | +20.0% |
AMLX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$25.25M(-36.6%) | -$165.65M(-20.0%) |
| Mar 2025 | - | -$39.82M(-32.5%) | -$206.98M(+23.5%) |
| Dec 2024 | -$167.65M(-1506.6%) | -$59.01M(+41.9%) | -$167.65M(+76.3%) |
| Sep 2024 | - | -$41.57M(-37.6%) | -$95.09M(+62.0%) |
| Jun 2024 | - | -$66.58M(>+9900.0%) | -$58.69M(-455.6%) |
| Mar 2024 | - | -$489.00K(-103.6%) | $16.50M(+38.5%) |
| Dec 2023 | $11.92M | $13.55M(-362.2%) | $11.92M(-123.2%) |
| Sep 2023 | - | -$5.17M(-160.0%) | -$51.33M(-42.5%) |
| Jun 2023 | - | $8.61M(-269.7%) | -$89.24M(-38.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$5.07M(-89.8%) | -$144.31M(-19.8%) |
| Dec 2022 | -$179.87M(+140.5%) | -$49.70M(+15.4%) | -$179.87M(+38.2%) |
| Sep 2022 | - | -$43.08M(-7.3%) | -$130.17M(+49.5%) |
| Jun 2022 | - | -$46.46M(+14.3%) | -$87.10M(+62.2%) |
| Mar 2022 | - | -$40.63M(+211.4%) | -$53.68M(+109.0%) |
| Dec 2021 | -$74.80M(+103.8%) | - | - |
| Jun 2021 | - | -$13.05M(+3.2%) | -$25.69M(+103.2%) |
| Mar 2021 | - | -$12.64M | -$12.64M |
| Dec 2020 | -$36.70M(+243.4%) | - | - |
| Dec 2019 | -$10.69M | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual CFO year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly CFO year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM CFO year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual cash flow from operations?
The current annual CFO of AMLX is -$167.65M
What is the all time high annual CFO for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual cash flow from operations is $11.92M
What is Amylyx Pharmaceuticals, Inc. annual CFO year-on-year change?
Over the past year, AMLX annual cash flow from operations has changed by -$179.57M (-1506.55%)
What is Amylyx Pharmaceuticals, Inc. quarterly cash flow from operations?
The current quarterly CFO of AMLX is -$25.25M
What is the all time high quarterly CFO for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly cash flow from operations is $13.55M
What is Amylyx Pharmaceuticals, Inc. quarterly CFO year-on-year change?
Over the past year, AMLX quarterly cash flow from operations has changed by +$41.33M (+62.08%)
What is Amylyx Pharmaceuticals, Inc. TTM cash flow from operations?
The current TTM CFO of AMLX is -$165.65M
What is the all time high TTM CFO for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM cash flow from operations is $16.50M
What is Amylyx Pharmaceuticals, Inc. TTM CFO year-on-year change?
Over the past year, AMLX TTM cash flow from operations has changed by -$106.96M (-182.26%)